title: [[Meldonium in treatment of patients with myocardial infarction].
abstract: Therapy with meldonium belongs to "metabolic direction" which is developing in cardiovascular medicine. Its purpose is restoration of impaired cellular metabolism.
authors.forename: G I
authors.initials: GI
authors.lastname: Nechaeva
authors.forename: D A
authors.initials: DA
authors.lastname: Potashov
authors.forename: E N
authors.initials: EN
authors.lastname: Zheltikova
mesh_terms: D002316:Cardiotonic Agents / Q000494:pharmacology; D002317:Cardiovascular Agents / Q000494:pharmacology; D006801:Humans; D008660:Metabolism; D008763:Methylhydrazines / Q000494:pharmacology*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D002317:Cardiovascular Agents; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate